Showing results (791-800 of 973) with videos related to

Sort By:
Pageof 98
Archives of Toxicology|June 6, 2022
Are the current commercially available oximes capable of reactivating acetylcholinesterase inhibited by the nerve agents of the A-series?Marcelo C Santos, Fernanda D Botelho, Arlan S Gonçalves, et al.
European Urology|May 13, 2023
Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 TrialOliver Sartor, Theodore G Karrison, Howard M Sandler, et al.
European Urology|June 19, 2024
Corrigendum to "Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostat Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial" [Eur. Eurol. 84(2) (2023) 156-163]Oliver Sartor, Theodore G Karrison, Howard M Sandler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2020
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized TrialDavid A Palma, Robert Olson, Stephen Harrow, et al.
Cancer|May 24, 2023
Stereotactic ablative radiotherapy before resection to avoid delay for early-stage lung cancer or oligometastases during the COVID-19 pandemic: Pathologic outcomes from the SABR-BRIDGE protocolBiniam Kidane, Ian J Gerard, Jonathan Spicer, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 21, 2021
Design, synthesis, <i>in silico</i> studies and <i>in vitro</i> evaluation of isatin-pyridine oximes hybrids as novel acetylcholinesterase reactivatorsDaniel A S Kitagawa, Rafael B Rodrigues, Thiago N Silva, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 29, 2021
An MDS Evidence-Based Review on Treatments for Huntington's DiseaseJoaquim J Ferreira, Filipe B Rodrigues, Gonçalo S Duarte, et al.
International Journal of Nanomedicine|March 15, 2014
Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery systemTatiana G Ribeiro, Miguel A Chávez-Fumagalli, Diogo G Valadares, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2019
Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 TrialSeth A Rosenthal, Chen Hu, Oliver Sartor, et al.
Biomolecules|October 11, 2019
In Vitro Evaluation of Neutral Aryloximes as Reactivators for <i>Electrophorus eel</i> Acetylcholinesterase Inhibited by ParaoxonDaniel A S Kitagawa, Samir F de A Cavalcante, Reuel L de Paula, et al.
Pageof 98